Director/PDMR Shareholding

Hikma Pharmaceuticals Plc

05 June 2024

 

Hikma Pharmaceuticals PLC

Notification and public disclosure of transactions by persons discharging managerial responsibilities

1	Details of the person discharging managerial responsibilities / person closely associated
a)	Name	Said Darwazah
2	Reason for the notification
a)	Position/status	Executive Chairman
b)	Initial notification /Amendment	Initial notification
3	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	Hikma Pharmaceuticals PLC
b)	LEI	549300BNS685UXH4JI75
4	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument, type of instrument and identification code	Description: Ordinary shares of 10 pence each ID Code: GB00B0LCW083
b)	Nature of the transaction	Grant of a pledge by the Executive Chairman over 820,416 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC in favour of EFG Private Bank UK Limited.
c)	Price(s) and volume(s)	Price(s): £0.00p Volume(s): 820,416
d)	Aggregated information	Aggregated volume: 820,416 Price: £0.00p
e)	Date of the transaction	31 May 2024
f)	Place of the transaction	Outside a trading venue

Helen Middlemist
Group Company Secretary

[phone]

 

END